1. Home
  2. VRAX vs HUSA Comparison

VRAX vs HUSA Comparison

Compare VRAX & HUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • HUSA
  • Stock Information
  • Founded
  • VRAX 2013
  • HUSA N/A
  • Country
  • VRAX United Kingdom
  • HUSA United States
  • Employees
  • VRAX N/A
  • HUSA N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • HUSA Oil & Gas Production
  • Sector
  • VRAX Health Care
  • HUSA Energy
  • Exchange
  • VRAX Nasdaq
  • HUSA Nasdaq
  • Market Cap
  • VRAX 17.2M
  • HUSA 14.4M
  • IPO Year
  • VRAX 2022
  • HUSA N/A
  • Fundamental
  • Price
  • VRAX $1.97
  • HUSA $1.57
  • Analyst Decision
  • VRAX
  • HUSA
  • Analyst Count
  • VRAX 0
  • HUSA 0
  • Target Price
  • VRAX N/A
  • HUSA N/A
  • AVG Volume (30 Days)
  • VRAX 4.9M
  • HUSA 558.2K
  • Earning Date
  • VRAX 11-26-2024
  • HUSA 11-22-2024
  • Dividend Yield
  • VRAX N/A
  • HUSA N/A
  • EPS Growth
  • VRAX N/A
  • HUSA N/A
  • EPS
  • VRAX N/A
  • HUSA N/A
  • Revenue
  • VRAX $156,419.00
  • HUSA $623,103.00
  • Revenue This Year
  • VRAX $5,169.18
  • HUSA N/A
  • Revenue Next Year
  • VRAX $66.97
  • HUSA N/A
  • P/E Ratio
  • VRAX N/A
  • HUSA N/A
  • Revenue Growth
  • VRAX 1727.11
  • HUSA N/A
  • 52 Week Low
  • VRAX $0.60
  • HUSA $0.96
  • 52 Week High
  • VRAX $9.00
  • HUSA $2.57
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 46.98
  • HUSA 58.17
  • Support Level
  • VRAX $1.92
  • HUSA $1.34
  • Resistance Level
  • VRAX $2.50
  • HUSA $1.42
  • Average True Range (ATR)
  • VRAX 0.22
  • HUSA 0.10
  • MACD
  • VRAX 0.01
  • HUSA 0.00
  • Stochastic Oscillator
  • VRAX 26.97
  • HUSA 63.89

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.

Share on Social Networks: